Xylocaine. The Pharmacological Basis of Its Clinical Use. SECOND EDITION

Wiedling, Sten

doi:10.1097/00000542-196505000-00029

Cited by 4 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lignocaine was selected for this series, its qualities of diffusion, quick onset of action and stability providing the results expected (Wiedling, 1959;Gruber, 1961).…”

Section: Discussionmentioning

confidence: 99%

Caudal Analgesia: A Simple and Safe Technique in Paediatric Surgery

Fortuna¹

1967

British Journal of Anaesthesia

View full text Add to dashboard Cite

A series of 170 infants and children were operated upon under caudal analgesia. Lignocaine was used in concentrations from 0.5 to 2 per cent. The average dose employed was 10 mg/kg body weight. Analgesia was satisfactory in 91.7 per cent of cases. Complete failure occurred in 5.2 per cent of patients. No serious accidents or complications were seen due to the anaesthetic method. In the author's experience this technique represents a safe, reliable and simple way to produce surgical analgesia in infants and children, especially in those needing emergency surgery who are in poor condition.

show abstract

“…Lignocaine was selected for this series, its qualities of diffusion, quick onset of action and stability providing the results expected (Wiedling, 1959;Gruber, 1961).…”

Section: Discussionmentioning

confidence: 99%

Caudal Analgesia: A Simple and Safe Technique in Paediatric Surgery

Fortuna¹

1967

British Journal of Anaesthesia

View full text Add to dashboard Cite

show abstract

“…. Corneal anesthesia [5]& [22] is an. indication not only of anesthetic potentiality, but also of the ability of the agent to penetrate the layers of cells.…”

Section: Methodsmentioning

confidence: 99%

Comparative Study Of Local Anaesthtic Action Of Bupivacaine With Standard Xyolocaine In Rabbits And Guniea Pigs.

Viswashanthi¹,

Gousebhasha²

2017

IOSR JDMS

View full text Add to dashboard Cite

“…Procainamide has been widely used, but the frequency of accompanying hvpotension remains a drawback to its routine use in acute myocardial infarction. Lignocaine, which is structurally similar to procainamide, was synthesized in 1943 by Lbfgren, and subsequently extensively investigated as a local anaesthetic agent (Wiedling, 1964). Southworth et al (1950) reported the successful use of lignocaine in association with alternating-current shock in a case of ventricular fibrillation arising during cardiac catheterization.…”

mentioning

confidence: 99%

Use of Lignocaine in Treatment of Cardiac Arrhythmias

Spracklen¹,

Kimerling²,

Besterman³

et al. 1969

Survey of Anesthesiology

View full text Add to dashboard Cite

Oral Lichen Planus-awson MWDi 'ICSoui 89 In 30 patients with oral lichen planus regarded as severe enough to justify treatment, use of betamethasone (Betnovate) pellets 0.1 mg. was followed by substantial improvement or complete clearance of oral lesions in 20. Seven patients showed gradual or incomplete improvement.Only 2 out of 30 patients failed to show any response to betamethasone, but treatment was not continued for more than one month in these cases. Of two patients with mucous membrane pemphigoid the use of betamethasone pellets was followed by complete clearance of oral lesions. A third patient showed substantial improvement until he ceased to attend.The only side-effect of treatment was development of thrusb in four patients.The assistance of Messrs. Glaxo in their generous supply of tablets and for other help for this trial is gratefully acknowledged.

show abstract

Xylocaine. The Pharmacological Basis of Its Clinical Use. SECOND EDITION

Cited by 4 publications

References 0 publications

Caudal Analgesia: A Simple and Safe Technique in Paediatric Surgery

Caudal Analgesia: A Simple and Safe Technique in Paediatric Surgery

Comparative Study Of Local Anaesthtic Action Of Bupivacaine With Standard Xyolocaine In Rabbits And Guniea Pigs.

Use of Lignocaine in Treatment of Cardiac Arrhythmias

Contact Info

Product

Resources

About